ARS Pharmaceuticals (SPRY) Revenue Growth (3y) (2025 - 2026)

ARS Pharmaceuticals (SPRY) Revenue Growth (3y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (3y) (Qtr)
1 Oculis Holding AG 66,681.27 Bn 66,680.98 Bn - -
2 Nanobiotix 1,911.83 Bn 1,911.77 Bn - -
3 Akari Therapeutics 959.56 Bn 959.56 Bn - -
4 BeOne Medicines 472.75 Bn 467.96 Bn 1.35 Bn 50.07%
5 Vertex Pharmaceuticals 122.14 Bn 114.89 Bn 2.59 Bn 7.94%
6 Regeneron Pharmaceuticals 70.09 Bn 61.34 Bn 3.31 Bn 4.47%
7 Belite Bio 62.34 Bn 62.34 Bn - -
8 Argenx Se 55.94 Bn 50.76 Bn 1.41 Bn 79.44%
9 Alnylam Pharmaceuticals 37.52 Bn 34.51 Bn 959.66 Mn 54.05%
10 ARS Pharmaceuticals 563.01 Mn 362.04 Mn - 942.82%

Historic Data

Download Data
DateValue
Mar 31, 2026 942.82%
Sep 30, 2025 456.09%
Jun 30, 2025 223.56%
Mar 31, 2025 129.11%